$HQL News

abrdn Life Sciences Investors Q1 2026 Commentary

HQL: Attractive Outlook With Growth Of GLP-1 Market

Abrdn Life Sciences Investors Fund Q4 2025 Commentary

Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts

HQL: Dividend Can Be Sustained Through 2026

Abrdn Life Sciences Investors Q3 2025 Commentary

abrdn Life Sciences Investors Q2 2025 Commentary

HQL: We Should Be Accumulating During The Weakness

ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS

ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS

CEF Insights: The Future Of Healthcare Investing

HQL: Attractive Valuation, Aligned To Benefit From Aging Gen X

abrdn Life Sciences Investors raises dividend by 2.1% to $0.49

abrdn Life Sciences Investors (HQL) Announces Results of Annual Meeting of Shareholders

HQL Makes Notable Cross Below Critical Moving Average

Tekla Life Sciences Investors Announce Renewal of Share Repurchase Program

Tekla Life Sciences Investors Declares Stock Distribution

Top Picks 2020- Tekla Life Sciences Fund HQL

Tekla Life Sciences Investors Declares $0.37 Stock Distribution A Share